Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00791817 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate Potential Food Effects
A Phase 1 study of Healthy, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00791817: Completed Phase 1 study of Healthy, sponsored by Procter and Gamble.
NCT00791817 is a Phase 1 study of Healthy that has completed, run by Procter and Gamble. The registered enrollment target is 10 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00791817, a Phase 1 study of Healthy, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Half the group will be given a high fat diet and the other half will fast. They will then be crossed over.
Primary Outcome
Maximum plasma concentration after a single dose
Conditions Studied
Interventions
- DRUG PG-760564
Study Locations (1)
Florida
- Stuart I Harris, MD, PhD - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
What the finished NCT00791817 record still lists
NCT00791817 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which PG-760564 is the first listed.
NCT00791817 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00791817 about?
NCT00791817 is a clinical study titled "Study to Evaluate Potential Food Effects". Half the group will be given a high fat diet and the other half will fast. They will then be crossed over.
What is the current status of trial NCT00791817?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2005-08. Estimated completion is 2006-01.
What conditions does trial NCT00791817 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT00791817?
The interventions under investigation include: PG-760564 (DRUG).
Who is sponsoring clinical trial NCT00791817?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00791817 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00791817's enrollment target sits among peer trials
10 1035th of 1090 higher than 35 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
RECRUITING · Phase 1
-
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
RECRUITING · Phase 1
-
Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging
RECRUITING · Phase 1
-
A Study of V118E in Healthy Participants (V118E-003)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia